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Abstract
Background: Long and persistent uncontrolled diabetes tends to degenerate the immune system and leads to an
increased incidence of infection. Whey proteins (WPs) enhance immunity during early life and have a protective
role in some immune disorders. In this study, the effects of camel WP on the chemotaxis of B and T cells to
CXCL12 and CCL21 in diabetic mice were investigated.
Results: Flow cytometric analysis of the surface expressions of CXCR4 (CXCL12 receptor) and CCR7 (CCL21
receptor) on B and T cells revealed that the surface expressions of CXCR4 and CCR7 were not significantly altered
in diabetic and WP-supplemented diabetic mice compared with control mice. Nevertheless, B and T lymphocytes
from diabetic mice were found to be in a stunned state, with a marked and significant (P < 0.05) decrease in
CXCL12- and CCL21-mediated actin polymerization and subsequently, a marked decrease in their chemotaxis. WP
supplementation in the diabetes model was found to significantly increase CXCL12- and CCL21-mediated actin
polymerization and chemotaxis in both B and T cells.
Conclusion: Our data revealed the benefits of WP supplementation in enhancing cytoskeletal rearrangement and
chemotaxis in B and T cells, and subsequently improving the immune response in diabetic mice.
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Background
Type 1 diabetes is defined as a complex multifactorial
disease in which genetic factors with environmental
modifiers give rise to immune abnormalities, leading to
pancreatic b-cell damage and destruction. Diabetes mel-
litus is usually associated with many metabolic compli-
cations [1]. In diabetic patients, infections occur with
greater frequency and severity than in non-diabetics due
to both humoral and cellular immune response impair-
ment [2]. Numerous defects have been identified in
CD8+ CD28 T-suppressor lymphocyte populations in
patients with type 1 diabetes mellitus and multiple
sclerosis [3]. Some evidence has suggested that defects
in immune cells might interfere with normal pancreatic
development and glucose homeostasis [4]. Additionally,
a recent study reported that diabetic patients have
demonstrable defects in lymphocyte function due to dis-
ruptions in potassium channels [5]. A previous investi-
gation demonstrated that monocytes isolated from
diabetic patients spontaneously secreted proinflamma-
tory cytokines, leading to an altered T cell response [6].
Secondary lymphoid tissues are sites of antigen recogni-
tion in which B and T cells associate with antigen-pre-
senting cells (APCs) to initiate an adaptive immune
response [7]. Chemokines play a crucial role in immune
cell chemotaxis. In particular, CCL21 participates in
naive T and B cell recruitment to the extra-follicular
area in secondary lymphoid organs [8]. These chemo-
kines, including CCL21 and CXCL12, are produced by
cells scattered throughout the extra-follicular area and
act through CXCR4 and CCR7, respectively, which are
* Correspondence: badr73@yahoo.com
1Zoology Department, College of Science, King Saud University, Saudi Arabia
Full list of author information is available at the end of the article
Badr et al. Lipids in Health and Disease 2011, 10:203
http://www.lipidworld.com/content/10/1/203
© 2011 Badr et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.specifically expressed on activated T and B cells [9].
During B and T cell chemotaxis, the actin cytoskeleton
is dynamically remodeled; this reorganization produces
the force necessary for the activation and migration of
these cells [10].
Whey proteins (WPs) represent a heterogeneous
group of proteins (i.e., b-lactoglobulin, a-lactalbumin,
serum albumin, and immunoglobulins). Indeed, recently
published data have suggested that WP has antioxidant
activity, likely due to cysteine abundance or the pre-
sence of glutamylcysteine groups, which are also found
in other food proteins. Therefore, WP may be a thera-
peutic tool for oxidative stress-associated diseases [11].
Previous studies have reported that WPs and peptides
derived from the enzymatic proteolysis of WPs modu-
late a variety of immune functions, including lympho-
cyte activation and proliferation, cytokine secretion,
antibody production, phagocytic activity, and granulo-
cyte and natural killer (NK) cell activity [12]. Another
study revealed that oral administration of an undena-
tured cysteine-rich WP isolate increased glutathione
(GSH) levels in several glutathione-deficient patient
groups, including patients with advanced human immu-
nodeficiency virus (HIV) [13]. In addition, in vitro and
in vivo studies have demonstrated a clear modulation of
immune functions by several whey protein-derived pro-
ducts [14]. Furthermore, whey peptides possess immu-
nomodulatory activities, such as stimulating
lymphocytes and increasing phagocytosis, and the secre-
tion of immunoglobulin A (IgA) from Peyer’s patches
[15]. Recently, it has been reported that WP has immu-
nomodulatory properties and the potential to increase
host defense [16], protective effects against childhood
asthma and atopic syndrome [17], and anticancer effects
[18].
To further elucidate the potential benefits of this pro-
tein, this study investigated the impact of dietary supple-
mentation with a camel WP on the actin polymerization
and chemotaxis of B and T cells in response to CXCL12
and CCL21 in diabetic mice.
Results
WP supplementation does not affect the surface
expression of CXCR4 and CCR7 on B and T cells in
diabetic mice
First, we analyzed the surface expressions of CXCR4 and
CCR7 by flow cytometry on B and T cells in control
mice, diabetic mice and diabetic mice supplemented
with WP using anti-CXCR4-PE, anti-CCR7-PE and IgG
isotype control antibodies. Histograms were gated based
on viable B220+ B cells (Figure 1A) and CD3+ T cells
(Figure 1B). We observed a slight but not significant
decrease in the surface expression of chemokine recep-
tors CXCR4 and CCR7 on both B and T cells in diabetic
mice compared with control mice. Additionally, WP
supplementation in the diabetes model had no signifi-
cant effects on the surface expressions of these
receptors.
Whey protein supplementation reverses the impairment
of chemokine-mediated actin polymerization in B cells in
diabetic mice
Actin and microtubules provide the dynamic cellular
framework required to orchestrate and ultimately con-
trol cellular activation, immunological synapse forma-
tion, proliferation and chemotaxis. Therefore,
chemokine-mediated actin polymerization was moni-
tored in B cells in the three animal groups. F-actin poly-
merization was measured in response to CXCL12
(Figure 2A) and CCL21 (Figure 2B) in B cells isolated
from control (open circles), diabetic (closed black cir-
cles), and WP-treated diabetic mice (closed gray trian-
gles). Fixed cells were analyzed by flow cytometry, and
the mean fluorescence intensity (MFI) was determined
for each sample. We found that the percentage of F-
actin polymerization was significantly reduced in dia-
betic mice compared with the control group upon sti-
mulation with CXCL12 or CCL21 every 15 seconds (P <
0.05; n = 10). In contrast, WP-treated diabetic mice
exhibited a significant increase in chemokine-mediated
actin polymerization.
Whey protein supplementation reverses impairment of
chemokine-mediated F-actin polymerization in T cells in
diabetic mice
As mentioned previously, actin and microtubules pro-
vide the dynamic cellular framework to orchestrate and
ultimately control T cell activation. Therefore, chemo-
kine-mediated actin polymerization was also monitored
in T cells in the three animal groups. The degree of F-
actin polymerization was determined by flow cytometry
in response to CXCL12 (Figure 3A) and CCL21 (Figure
3B). We observed that the percentage of F-actin poly-
merization was significantly reduced in diabetic mice
(closed black circles) compared with the control mice
(open circles) upon stimulation with CXCL12 or CCL21
every 15 seconds (P < 0.05; n = 8). In contrast, WP sup-
plementation was found to partially restore the impair-
ment of chemokine-induced F-actin polymerization in T
cells in diabetic mice.
Supplementation with WP improves and partially restores
B cell chemotaxis in diabetic mice
We assessed the chemotactic response of B cells isolated
from the spleens of 10 mice from each group to
CXCL12 and CCL21. Input and migrated cell popula-
tions were stained with B220-APC, IgD-PE and CD44-
FITC. Dot plots of input cells and transmigrated cells to
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CXCL12 for control mice are shown in Figure 4A (one
representative experiment is shown) with the input and
transmigrated B cell population data. Additionally, the
percentages of B cell chemotaxis to CXCL12 and
CCL21 from the control (open bars), diabetic (closed,
black bars) and WP-treated diabetic (closed, gray bars)
groups that specifically migrated to chemokines are
shown in Figure 4B. These data revealed that the per-
centage of B cell chemotaxis was significantly decreased
in diabetic mice compared with the control group (*P <
0.05), whereas WP-treated diabetic mice exhibited a sig-
nificant increase in B cell chemotaxis compared with
untreated diabetic mice (
#P < 0.05).
WP supplementation improves T cell chemotaxis in
diabetic mice
The percentage of T cells isolated from the spleens and
peripheral lymph nodes (PLNs) that specifically migrated
were assessed with flow cytometry. Input populations
Figure 1 Surface expression of CXCR4 and CCR7 on B and T cells. Surface CXCR4 and CCR7 expression levels were analyzed with flow
cytometry on B and T cells of the control mice (open histograms, thin line), diabetic mice (open histograms, black bold line) and diabetic mice
supplemented with WP (gray-filled histograms, thin line) using anti-CXCR4-PE, anti-CCR7-PE and IgG (open histogram) isotype control antibodies.
Histograms were gated based on viable B220+ B cells (A) and CD3+ T cells (B).
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FITC. The percentages of T cells in control (open bars),
diabetic (closed, black bars) and WP-treated diabetic
(closed, gray bars) groups that specifically migrated to
chemokines are shown (Figure 5). Our data demon-
strated that the percentage of T cell chemotaxis was
significantly decreased in diabetic mice compared with
control mice (*P <0 . 0 5 ;n = 10), and WP-treated dia-
betic mice exhibited a significant increase in T cell che-
motaxis compared with untreated diabetic mice (
#P <
0.05; n = 10).
Discussion
Antioxidants play a vital role in maintaining immunity
and protection against free radical damage in the
Figure 2 Impact of WP supplementation on actin polymerization
in B cells. B cells were isolated from control (open circles), diabetic
(closed black circles), and WP-treated diabetic groups (closed gray
triangles). F-actin polymerization was measured in response to CXCL12
(A) and CCL21 (B). The results are expressed as the percentage
changes in MFI (n = 10) ± SD as described in the Materials and
Methods section.
Figure 3 Impact of WP supplementation on actin polymerization
in T cells. T cells were isolated from the control (open circles), diabetic
(closed black circles), and WP-treated diabetic groups (closed gray
triangles). F-actin polymerization was measured in response to CXCL12
(A) and CCL21 (B). The results are expressed as the percentage
changes in MFI (n = 8) ± SD as described in the Materials and
Methods section.
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many different diseases, including fatty liver disease [19],
cardiovascular diseases [20], colitis [21], HIV infection
[13], and cancer [18]. CXCL12 and CCL21, via their
cognate receptors (CXCR4 and CCR7, respectively), play
a central role in lymphocyte trafficking and homing to
secondary lymphoid organs, where they recognize pre-
sented antigens. CCR7 and CXCR4 are expressed on all
naive T cells, some memory T cells, B cells, and mature
dendritic cells and play a central role in lymphocyte
trafficking and homing to lymph nodes. We first moni-
tored the surface expression of CXCR4 and CCR7 with
flow cytometry on B and T cells in control mice,
untreated diabetic mice and diabetic mice supplemented
with WP. We observed that there were no significant
differences in the surface expression of CXCR4 and
CCR7 in both B and T cells in all groups throughout
the experimental period. Although WP supplementation
did not affect the surface expression of CXCR4 and
CCR7 on B and T cells, the activity and underlying sig-
naling proteins of these receptors might be altered; this
requires further study. Actin polymerization plays a cri-
tical role in lymphocyte activation and subsequent sig-
naling, cell migration, morphogenesis, cellular
trafficking, cytokinesis and cell proliferation [22]. In this
study, it was determined that WP supplementation
reversed chemokine-mediated actin polymerization
impairment in both B and T cells in diabetic mice.
Figure 4 Whey protein restores B cell chemotaxis in diabetic
mice. Splenic B cells were isolated from 10 mice in each group and
were analyzed for migration to CXCL12 and CCL21. Input
populations and migrated cell populations were stained with B220-
APC and IgD-PE/CD44-FITC. Representative dot plots of input cells
and transmigrated cells to medium (without chemokine) versus
medium containing CXCL12 for control mice are shown, including the
input and transmigrated B cell population data. Data from one
representative experiment are shown in panel A. The percentage of B
cells from 10 different mice in the control (open bars), diabetic (closed,
black bars) and WP-treated diabetic (closed, gray bars) groups that
specifically migrated to chemokines are shown. The results are
expressed as the mean specific migration ± SEM. *P < 0.05, diabetic vs.
control;
#P < 0.05, diabetic vs. WP-treated groups.
Figure 5 Whey protein restores T cell chemotaxis in diabetic
mice. T cells were isolated from 10 mice in each group and
analyzed for migration to CXCL12 and CCL21. Input populations and
migrated cell populations were stained with CD3-FITC. The
percentage of T cells from 10 different mice in the control (open
bars), diabetic (closed, black bars) and WP-treated diabetic (closed,
gray bars) groups that specifically migrated to chemokines are
shown. The results are expressed as the mean specific migration ±
SEM. *P < 0.05, diabetic vs. control;
#P < 0.05, diabetic vs. WP-
treated groups.
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observed actin polymerization impairment in type 2 dia-
betes. To our knowledge, we show for the first time that
WP increased chemokine-mediated actin polymerization
in these lymphocytes. Defective actin polymerization
leads to long-term T cell unresponsiveness or anergy
[24]. Our results are in agreement with the results of
[25], who found that vitamin C sustains TCR-mediated
actin polymerization and T cell responsiveness in strep-
tozotocin-induced diabetic rats. Chemotaxis is an essen-
tial phenomenon for shaping immune responses, and
chemokine-receptor antagonists are now being evaluated
as therapies for various inflammatory and autoimmune
diseases. In this study, these data revealed that the per-
centage of chemotactic B cells was significantly impaired
in diabetic mice, whereas WP-treated diabetic groups
exhibited significant increases in chemotactic B and T
cells. A previous study reported that CD34+ cells iso-
lated from diabetic patients demonstrated a marked
defect in migration to SDF-1 (i.e., CXCL12), supporting
our results [26]. Moreover, previous investigations have
shown that the CXCR4/CXCL12 (SDF-1) signaling path-
way protects non-obese diabetic mice from autoimmune
diabetes [27]. Our results showed that WP increased
CCL21- and CXCL12-mediated B and T cells chemo-
taxis in diabetic mice, which is considered a unique and
major finding. Previous studies have shown that CCR7
and CXCR4 are involved in the recruitment of blood-
borne leukocytes to sites of inflammation [28]. As recep-
tors, CXCR4 and CCR7 can be considered activation
markers [29]. Recently, reports have shown that bovine
WP enhances innate immunity by increasing neutrophil
chemotaxis [30]. Our data suggest improved B and T
cell chemotaxis efficiency following WP treatment in
diabetic mice.
Conclusions
In conclusion, these data expand our knowledge of WP
supplementation in enhancing the immune response in
diabetic mice by increasing chemokine-mediated actin
polymerization and chemotaxis in both B and T cells,
suggesting that WP may be a promising drug candidate
for immunomodulation.
Materials and methods
Preparation of whey proteins
Raw camel milk was collected from healthy female
camels (three camel breeds: Majaheim, Maghateer, and
Soffer) from the Riyadh area in Saudi Arabia. The milk
was then centrifuged to remove the cream. The skim
milk obtained was acidified to pH 4.3 using 1 N HCl at
room temperature and centrifuged at 10,000 × g for 10
min to precipitate the casein. The resultant whey, which
contained the whey proteins, was saturated with
ammonium sulfate to a final saturation of 80% to preci-
pitate the whey proteins. The precipitated whey proteins
were dialyzed against 20 volumes of distilled water for
48 hr using a molecular-porous membrane with an
Molecular Weight Cut Off (MWCO) of 6,000-8,000
kDa. The dialysate containing undenatured whey pro-
teins was freeze-dried and refrigerated until use.
Chemicals
Streptozotocin (STZ) was obtained from Sigma Chemi-
cals Co., St. Louis, MO, USA. STZ was dissolved in cold
0.01 M citrate buffer (pH 4.50) and was always freshly
prepared for immediate use (within 5 min).
Animals and experimental design
A total of 30 sexually mature 12-week-old male mice
weighing 25-30 g each were obtained from the Central
Animal House of the Faculty of Pharmacy at King Saud
University. All animal procedures were conducted in
accordance with the standards set forth in the Guide-
lines for the Care and Use of Experimental Animals by
the Committee for the Purpose of Control and Supervi-
sion of Experiments on Animals (CPCSEA) and the
National Institutes of Health (NIH). The study protocol
was approved by the Animal Ethics Committee of the
Zoology Department, College of Science, King Saud
University according to the Helsinki principles. All ani-
mals were allowed to acclimate to the metal cages inside
a well-ventilated room for 2 weeks prior to experimen-
tation. Animals were maintained under standard labora-
tory conditions (temperature 23°C, relative humidity 60-
70% and a 12-hour light/dark cycle), fed a diet of stan-
dard commercial pellets and given water ad libitum. All
mice were fasted for 20 hr before diabetes induction.
Mice (n = 20) were rendered diabetic with an intraperi-
toneal injection (i.p.) of a single dose of STZ (60 mg/kg
body weight) in 0.01 M citrate buffer (pH 4.5) [31].
Mice in the control group (n = 10) were injected with
the vehicle alone (0.01 M citrate buffer, pH 4.5). The
animals were divided into three experimental groups:
group 1, control non-diabetic mice; group 2, diabetic
mice; and group 3, diabetic mice orally supplemented
with undenatured WP (100 mg/kg body weight/day for
one month through oral gavage).
Total lymphocyte and B and T cell isolation
Lymphocytes were isolated from the spleens and PLNs
of adult male mice. Lymph nodes and spleens were
homogenized using 40-μm cell strainers (BD Falcon,
Bedford, MA, USA). Red blood cells from spleens were
osmotically lysed using ACK buffer. Cells were washed
with phosphate-buffered saline (PBS), counted using the
trypan blue exclusion test, and cultured in R-10 culture
medium (complete RPMI 1640 medium supplemented
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100 μg/ml streptomycin, 1 mM sodium pyruvate, and
50 μM 2-mercaptoethanol).
Splenic B cells were isolated by negative depletion by
using biotinylated antibodies against CD4, CD8, GR-1,
and CDllc and Dynabeads M-280 Streptavidin (Invitro-
gen, France) as previously described [32]. Splenic T cells
were also isolated using negative selection columns. Cell
purity was assessed with flow cytometry and was greater
than 95%. Cells were cultured in R-10 medium.
Antibodies and flow cytometry
Lymphocytes from PLNs, spleens, blood and purified
cell populations (1 × 10
6 cells per 50 μlP B S )w e r e
blocked with purified CD16/CD32 FccII/III mAb to pre-
vent non-specific binding. Subsequently, cells were
stained with mAbs and analyzed using a FACSCalibur
flow cytometer (BD, Franklin Lakes, NJ, USA). Antibo-
d i e sa g a i n s tm o u s eC D 1 1 b ,C D 1 1 c ,C D 3 ,C D 4 ,C D 8 a ,
and B220 were purchased fromB DP h a r m i n g e n .A n t i -
mouse CCR7, CXCR4, CCL21 and CXCL12 were pur-
chased from R&D Systems.
F-actin polymerization assay
Intracellular F-actin polymerization was assessed as pre-
viously described [9]. Cells from each group (8 × 10
6/
ml) were incubated in HEPES-buffered RPMI 1640 at
37°C and stimulated with or without chemokines. At the
indicated times, cells (100 μl) were added to 400 μlo f
assay buffer containing 4 × 10
-7 M FITC-labeled phalloi-
din, 0.5 mg/ml L-a- lysophosphatidylcholine (both from
Sigma-Aldrich) and 4.5% formaldehyde in PBS. Fixed
cells were analyzed with flow cytometry, and the mean
fluorescence intensity (MFI) was determined for each
sample. The percent change in MFI was calculated for
each sample at each time point as follows: [1-(MFI
before addition of chemokine/MFI and after addition of
chemokine)] × 100.
In vitro chemotaxis assay
The chemotaxis of B and T cells was measured using
migration through polycarbonate filters with a 3-μm
pore size in 24-well transwell chambers (Corning Costar,
Cambridge, MA, USA) as previously described [25].
Briefly, 1 × 10
5 B or T cells or DCs in 100 μlo fp r e -
warmed migration medium (RPMI 1640 containing 10
mM HEPES and 1% FBS) were added to the upper
chamber. A total of 600 μl of migration medium con-
taining 250 ng/ml CCL21 or CXCL12 or medium alone
as a control for spontaneous migration was added to the
lower chamber, and the cells were incubated for 3 hours
at 37°C. Cells that transmigrated to the bottom chamber
were collected and counted with flow cytometry
(FACSCalibur, BD, Franklin Lakes, NJ) for a fixed period
of 60 seconds. The mean number of spontaneously
migrated cells was subtracted from the total number of
migrated cells. The results are shown as the percentage
of specific migration ± SEM.
Statistical analysis
Data are expressed as the mean ± SEM (standard error
of the mean). Significant differences between groups
were analyzed with a one-way analysis of variance (for
more than two groups) followed by Tukey’s post-test
using SPSS software, version 17. Differences were con-
sidered statistically significant at P < 0.05.
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